Avalyn Pharma (AVLN) vs Innoviva (INVA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Innoviva is the larger company by market cap ($1.31 billion vs $1.26 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVLN | INVA |
|---|---|---|
| Share price | $28.40 | $18.41 |
| Market cap | $1.26B | $1.31B |
| 1-day change | -1.05% | 0.00% |
| YTD return | — | -7.90% |
| 1-year return | — | -12.17% |
| 5-year return | — | +8.81% |
| P/E ratio (TTM) | — | 7.83 |
| Forward P/E | — | 8.33 |
| EPS (TTM) | $-3.96 | $2.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $411.33M |
| Revenue growth (YoY) | — | +14.67% |
| Net income (latest FY) | — | $271.17M |
| Gross margin | — | 74.80% |
| Operating margin | — | 39.81% |
| Net margin | — | 65.92% |
| 52-week high | $40.17 | $25.15 |
| 52-week low | $22.24 | $18.19 |
| Distance from 52-week high | -29.30% | -26.80% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +114.79% | +89.03% |
| Average volume | 352.95K | 865.66K |
| Shares outstanding | 44.52M | 71.08M |
| Employees | 56 | 159 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Avalyn Pharma
AVLN stock →Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 56 employees
About Innoviva
INVA stock →Innoviva, Inc. operates as a biopharmaceutical company in the United States and internationally.
Health Care · Biotechnology: Pharmaceutical Preparations · 159 employees
AVLN vs INVA FAQ
Which is bigger, Avalyn Pharma or Innoviva?
Innoviva (INVA) is larger, with a market capitalization of $1.31B compared with $1.26B for Avalyn Pharma (AVLN).
Are Avalyn Pharma and Innoviva in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.